CStone Pharmaceuticals Company

CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide.

Founded Date: 2015
Technology: Biologics
Funding Status: IPO
Employee Number: 101-250
Headquarters: China
Estimated Revenue: $1M to $10M
Industry: Genomic and Epigenominc Instabillity